JUAN FRANCISCO
DELGADO JIMÉNEZ
Profesor titular de universidad
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Cardiovasculares Carlos III (21)
2023
-
Differences in clinical outcomes, health care resource utilization and costs in heart failure patients according to left ventricular ejection fraction
Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 862-871
-
β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial
European Journal of Heart Failure, Vol. 25, Núm. 3, pp. 373-385
2022
-
Can we improve care for heart failure in Spain?
Medicina Clinica, Vol. 159, Núm. 2, pp. 90-91
-
Interaction between VA-ECMO and the right ventricle
Hellenic Journal of Cardiology, Vol. 68, pp. 17-24
-
Primary vs. Secondary Heart Failure Diagnosis: Differences in Clinical Outcomes, Healthcare Resource Utilization and Cost
Frontiers in Cardiovascular Medicine, Vol. 9
-
Rationale and Protocol of the Multimodality Evaluation of Antibody-Mediated Injury in Heart Transplantation (LEONE-HT) Observational Cross-Sectional Study
Methods and Protocols, Vol. 5, Núm. 5
-
Response by Caravaca Pérez et al to Letter Regarding Article, "potential Role of Natriuretic Response to Furosemide Stress Test during Acute Heart Failure"
Circulation: Heart Failure
-
Serum potassium dynamics during acute heart failure hospitalization
Clinical Research in Cardiology, Vol. 111, Núm. 4, pp. 368-379
2021
-
Potential Role of Natriuretic Response to Furosemide Stress Test during Acute Heart Failure
Circulation: Heart Failure, Vol. 14, Núm. 6, pp. E008166
-
Reply to G. Betts’s letter referring to “Serum potassium dynamics during acute heart failure hospitalization”
Clinical Research in Cardiology
-
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
Frontiers in Cardiovascular Medicine, Vol. 8
2020
-
A new mutation affecting the converter region of the beta-myosin heavy chain related to hypertrophic cardiomyopathy with poor prognosis
Revista Espanola de Cardiologia, Vol. 73, Núm. 2, pp. 180-183
-
Changes in causes of death and influence of therapeutic improvement over time in patients with heart failure and reduced ejection fraction
Revista Espanola de Cardiologia, Vol. 73, Núm. 7, pp. 561-568
-
Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5
Heart Rhythm, Vol. 17, Núm. 6, pp. 945-954
-
Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial
JACC: Basic to Translational Science, Vol. 5, Núm. 4, pp. 317-327
-
Effect of coronavirus disease 2019 in pulmonary circulation. The particular scenario of precapillary pulmonary hypertension
Diagnostics, Vol. 10, Núm. 8
-
Influence of long-standing pulmonary arterial hypertension and its severity on pulmonary artery aneurysm development
Heart and Vessels, Vol. 35, Núm. 9, pp. 1290-1298
-
Potential molecular pathways related to pulmonary artery aneurysm development: Lessons to learn from the aorta
International Journal of Molecular Sciences, Vol. 21, Núm. 7
2019
-
Evaluation of a nurse-led intervention program in heart failure: A randomized trial
Medicina Clinica, Vol. 152, Núm. 11, pp. 431-437
-
Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes
Nephrology Dialysis Transplantation, Vol. 34, Núm. 11, pp. 1864-1875